To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia

Clinical trial NCT06646354 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06646354
Sponsor: Hyundai Pharm
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension Primary Hypercholesterolaemia

Start date: 2025-04-22
Primary completion: 2025-05-19
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.